drug

cefdinir

Marketedupdated 3mo ago

by Orchid Pharma Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying cefdinir

phase1Cefdinir for Oral Suspension 250 mg/5mL, Fastingcompletedn=32
phase1Cefdinir Capsules 300 mg, Fastingcompletedn=32
phase1Cefdinir Capsules 300 mg, Non-fastingcompletedn=32
phase1Cefdinir for Oral Suspension 250 mg/5mL, Non-fastingcompletedn=32

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 13m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

cefdinir

Marketedupdated 3mo ago

by Orchid Pharma Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying cefdinir

phase1Cefdinir for Oral Suspension 250 mg/5mL, Fastingcompletedn=32
phase1Cefdinir Capsules 300 mg, Fastingcompletedn=32
phase1Cefdinir Capsules 300 mg, Non-fastingcompletedn=32
phase1Cefdinir for Oral Suspension 250 mg/5mL, Non-fastingcompletedn=32

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 13m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

cefdinir

all catalysts(0)

Trials studying cefdinir

News(0)

Report a data issue

comments(0)

cefdinir

all catalysts(0)

Trials studying cefdinir

News(0)

Report a data issue

comments(0)